Previous close | 16,175.00 |
Open | 16,071.01 |
Bid | 15,754.21 x 100 |
Ask | 0.00 x 10000 |
Day's range | 16,071.01 - 16,071.01 |
52-week range | 7,452.75 - 16,799.99 |
Volume | |
Avg. volume | 242 |
Market cap | 15.429T |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | 128.21 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 95.34 (0.59%) |
Ex-dividend date | 15 May 2024 |
1y target est | N/A |
Zepbound and related products could generate more than $50 billion of sales in 2029. There is a lot more in Lilly’s pipeline.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.